EX-99.1 3 dex991.htm PRESS RELEASE FOR MICROSEMI CORP Press Release for Microsemi Corp

Exhibit 99.1

 

FINANCIAL CONTACT: David R. Sonksen

 

Executive Vice President and Chief Financial Officer

Tel: (949) 221-7101

 

EDITORIAL CONTACT: Cliff Silver

 

Manager, Corporate Communications

Tel: (949) 221-7112

 

Microsemi Reports Fiscal 2003 and

Fourth Quarter Results

 

  Fourth Quarter Pro Forma Net Income Is $0.01 Per Share Greater than First Call’s Average of Broker Estimates

 

  Net Sales in Fourth Quarter Increase 5% over Third Quarter

 

  Positive Book-to-Bill Ratio in Fourth Quarter

 

  Gross Margins Increase 50 Basis Points over Third Quarter

 

  Pro Forma Net Income Increases 57% over Third Quarter

 

  GAAP Net Income up 33% over Third Quarter

 

Irvine, CA—(BusinessWire)—November 20, 2003—Microsemi Corporation (Nasdaq: MSCC) today reported results for its fourth quarter ended September 28, 2003 and the full 2003 fiscal year.

 

For the fourth quarter, net sales were $52.8 million, an increase of 7% from net sales of $49.2 million in the year-ago fourth quarter and an increase of 5% from net sales of $50.5 million in the third quarter. Fourth quarter pro forma net income was $2.2 million, or $0.07 per share diluted, up 175% from $0.8 million, or $0.03 per share diluted, in the year-ago fourth quarter and up 57% from the $1.4 million, or $0.05 per share diluted, in the third quarter. Pro forma gross margins for the fourth quarter were 32.8%, a 50 basis point improvement over the third quarter pro forma gross margin of 32.3% and an 80 basis point improvement over the 32.0% pro forma gross margin in the year ago fourth quarter.

 

For the fiscal year, net sales were $197.4 million, down 7% compared to last fiscal year’s net sales of $212.6 million. Fiscal year 2003 pro forma net income totaled $4.5 million, or $0.15 per share diluted, down 53% compared to pro forma net income of $9.6 million, or $0.32 per share diluted, in fiscal year 2002.

 

For the fourth quarter, Microsemi reported GAAP earnings of $1.6 million, or $0.05 per diluted share, compared to a loss of $7.1 million, or $0.24 per share diluted, in the year-ago fourth quarter and earnings of $1.2 million, or $0.04 per diluted share, in the third quarter.

 

For the full fiscal year 2003, in accordance with GAAP, Microsemi reported a loss of $11.5 million, or $0.40 per share diluted, compared to a loss of $4.7 million, or $0.16 per share diluted, in fiscal year 2002.

 

As detailed in the attached “Schedule Reconciling Pro Forma Earnings to GAAP Earnings,” the GAAP loss for fiscal year 2003 includes the transition year impairment of goodwill of $14.7 million after tax, for the cumulative effect of a change in accounting principle, retroactively to September 30, 2002, in accordance with the adoption of SFAS 142 “Goodwill and Other Intangible Assets,” as well as amortization of acquisition related intangible assets, restructuring costs and other special charges and credits.

 

The book-to-bill ratio for the quarter was 1.07.


“We are very pleased with our results for the fourth quarter”, stated James J. Peterson, President and CEO. “Net sales and pro forma earnings have increased for three consecutive quarters and we see continuing strength in all our markets.”

 

Business Outlook

 

The Company’s current outlook for net sales in the first quarter of fiscal year 2004 is 2 to 5 percent greater than the net sales in the fourth quarter. Pro forma earnings per share diluted for the first quarter are currently expected to be between $0.08 and $0.10. The gross margin percentage for the first quarter is expected to increase 20 to 50 basis points over the fourth quarter. Excluding the effect of any restructuring charges from our Consolidation program, earnings in the first quarter of fiscal year 2004, in accordance with GAAP, are expected to be $0.07 to $0.09 per share diluted, including a $0.2 million after-tax charge for amortization of acquisition-related intangible assets.

 

About Microsemi

 

Microsemi is a leading designer, manufacturer and marketer of analog, mixed-signal and discrete semiconductors. The company’s semiconductors typically manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals.

 

Microsemi’s products include individual components as well as complete circuit solutions that enhance customer designs by improving reliability, battery optimization, reducing size or protecting circuits. Markets the company serves include mobile connectivity, computer/peripherals, datacom, medical, industrial, automotive, digital media, space/satellite and military.

 

More information may be obtained by contacting the company directly or by visiting its web site at http://www.microsemi.com.

 

PLEASE READ THE FOLLOWING FACTORS THAT CAN MATERIALLY AFFECT MICROSEMI’S FUTURE RESULTS.

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in the news release that are not entirely historical and factual in nature are forward-looking statements. For instance, all statements of belief and expectations are forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Potential risks and uncertainties include, but are not limited to, such factors as the difficulties regarding the making of estimates and projections, the hiring and retention of qualified personnel in a competitive labor market, acquiring and integrating new operations or assets, closing or disposing of operations or assets, rapidly changing technology and product obsolescence, the potential inability to realize cost savings or productivity gains and to improve capacity utilization, potential cost increases, weakness or competitive pricing environment of the marketplace, uncertain demand for and acceptance of the company’s products, results of in-process or planned development or marketing and promotional campaigns, changes in demand for products, difficulties foreseeing future demand, effects of limited visibility of future sales, potential non-realization of expected orders or non-realization of backlog, product returns, product liability, and other potential unexpected business and economic conditions or adverse changes in current or expected industry conditions, business disruptions, epidemics, disasters, wars or potential future effects of the tragic events of September 11, variations in customer order preferences, fluctuations in market prices of the company’s common stock and potential unavailability of additional capital on favorable terms, difficulties in implementing company strategies, dealing with environmental matters or litigation, difficulties in determining and maintaining adequate insurance coverage, difficulties protecting patents and other proprietary rights, inventory obsolescence and customer qualification of products, manufacturing facilities and processes. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in the company’s most recent Form 10-K filed on December 19, 2002, and the Form 10-Q filed on August 12, 2003, by Microsemi with the Securities and Exchange


Commission which relates to the third quarter. Additional risk factors may be identified from time to time in Microsemi’s future filings, including the Form 10-K which will be filed that relates to the fiscal year. Microsemi does not undertake to supplement or correct any information in this release that is or becomes incorrect.

 

Investor Inquiries: David R. Sonksen, Microsemi Corporation, Irvine, CA (949) 221-7101.

 

(Financial Tables Follow)


MICROSEMI CORPORATION

Pro Forma Consolidated Income Statements

(In thousands, except per share amounts)

 

     Quarters ended

   Fiscal years ended

 
    

September 29,

2002


   

September 28,

2003


  

September 29,

2002


   

September 28,

2003


 

NET SALES

   $ 49,187     $ 52,751    $ 212,640     $ 197,371  

Cost of sales

     33,435       35,438      137,709       134,228  
    


 

  


 


GROSS MARGIN

     15,752       17,313      74,931       63,143  
Operating expenses:                                

Selling, general and administrative

     8,648       9,547      37,271       37,006  

Research and development

     5,792       4,606      22,855       19,368  
    


 

  


 


Total operating expenses

     14,440       14,153      60,126       56,374  
    


 

  


 


OPERATING INCOME

     1,312       3,160      14,805       6,769  

Interest and other expense, net

     (51 )     81      (463 )     (15 )
    


 

  


 


INCOME BEFORE INCOME TAXES

     1,261       3,241      14,342       6,754  

Provision for income taxes

     416       1,070      4,733       2,229  
    


 

  


 


PRO FORMA NET INCOME

   $ 845     $ 2,171    $ 9,609     $ 4,525  
    


 

  


 


Pro Forma Earnings per share:

                               

Basic

   $ 0.03     $ 0.07    $ 0.34     $ 0.15  

Diluted

   $ 0.03     $ 0.07    $ 0.32     $ 0.15  

Common and common equivalent shares outstanding:

                               

Basic

     28,888       29,020      28,676       28,953  

Diluted

     29,101       30,153      29,633       29,494  


MICROSEMI CORPORATION

Schedule Reconciling Pro Forma Earnings to GAAP Earnings

(in thousands, except per share amounts)

 

The pro forma amounts have been adjusted to exclude the following items:

 

     Quarters ended

    Fiscal years ended

 
    

September 29,

2002


   

September 28,

2003


   

September 29,

2002


   

September 28,

2003


 

Amortization of goodwill and other intangible assets

   $ (910 )   $ (304 )   $ (3,811 )   $ (1,320 )

Restructuring charges:

                                

Inventory write-off

     (3,005 )     —         (4,931 )     (200 )

Workforce reduction

     (2,103 )     —         (4,747 )     (686 )

Facility and asset abandonment

     (55 )     —         (1,974 )     (477 )

Loss from operations sold

     (796 )     —         (796 )     —    

Relocation of operations

     (71 )     —         (452 )     —    

Excess manufacturing cost

     (2,717 )     (294 )     (3,676 )     (878 )

Reorganization charges

     —         —         —         (509 )

Assets impairment

     (694 )     —         (2,381 )     (22,705 )

Reserve for future clean up cost

     —         (538 )     —         (538 )

Non-recurring gain on sales of assets, net

     (1,467 )     212       1,398       2,605  
    


 


 


 


       (11,818 )     (924 )     (21,370 )     (24,708 )

Income tax effect

     3,900       305       7,052       8,711  
    


 


 


 


Net effect of pro forma adjustments on net income

   $ (7,918 )   $ (619 )   $ (14,318 )   $ (15,997 )
    


 


 


 


Adjustments on earnings (loss) per share:

                                

Basic

   $ (0.27 )   $ (0.02 )   $ (0.50 )   $ (0.55 )

Diluted

   $ (0.27 )   $ (0.02 )   $ (0.50 )   $ (0.55 )

Common and common equivalent shares outstanding:

                                

Basic

     28,888       29,020       28,676       28,953  

Diluted

     28,888       29,020       28,676       28,953  

 

To supplement the consolidated financial results prepared under generally accepted accounting principles (“GAAP”), Microsemi uses a non-GAAP conforming, or pro forma measure of net income that equals GAAP net income adjusted to exclude certain costs, expenses and gains. Pro forma net income gives an indication of Microsemi’s baseline performance in regard to the operating results before gains, losses or other charges that are considered by management to be outside of the company’s core operating results. In addition, pro forma net income is among the primary indicators management uses as a basis for planning and forecasting future periods. These measures are not in accordance with, or an alternative for, GAAP and may be materially different from pro forma measures used by other companies. Microsemi computes pro forma net income principally by adjusting GAAP net income with the impact of acquisition-related charges, restructuring charges, and other non-recurring charges and credits.

 

-more-


MICROSEMI CORPORATION

Unaudited Consolidated Income Statements

(In thousands, except per share amounts)

 

     Quarter ended

    Fiscal years ended

 
    

September 29,

2002


   

September 28,

2003


   

September 29,

2002


   

September 28,

2003


 

NET SALES

   $ 49,187     $ 52,751     $ 212,640     $ 197,371  

Cost of sales

     39,228       36,270       146,782       136,830  
    


 


 


 


GROSS MARGIN

     9,959       16,481       65,858       60,541  
Operating expenses:                                 

Selling, general and administrative

     8,648       9,547       37,750       37,006  

Research and development

     6,588       4,606       23,651       19,368  

Amortization of goodwill and other intangible assets

     910       304       3,811       1,320  

Restructuring charges

     2,158       —         6,228       686  

Gain on sales of assets

     —         (212 )     —         (2,605 )

Asset impairment

     694       —         2,381       —    
    


 


 


 


Total operating expenses

     18,998       14,245       73,821       55,775  
    


 


 


 


OPERATING INCOME (LOSS)

     (9,039 )     2,236       (7,963 )     4,766  

Interest and other expense, net

     (1,518 )     81       935       (15 )
    


 


 


 


INCOME (LOSS) BEFORE INCOME TAXES

     (10,557 )     2,317       (7,028 )     4,751  

Provision (Benefit) for income taxes

     (3,484 )     765       (2,319 )     1,568  
    


 


 


 


Income (loss) before cumulative effect of a change in accounting principle

     (7,073 )     1,552       (4,709 )     3,183  

Cumulative effect of a change in accounting principle, net of income taxes

     —         —         —         (14,655 )
    


 


 


 


Net income (loss)

   $ (7,073 )   $ 1,552     $ (4,709 )   $ (11,472 )
    


 


 


 


Earnings (loss) per share:                                 
Basic earnings (loss) per share:                                 

Earnings (loss) per share before cumulative effect of accounting change

   $ (0.24 )   $ 0.05     $ (0.16 )   $ 0.11  

Cumulative effect of accounting change

     —         —         —         (0.51 )
    


 


 


 


Earnings (loss) per share

   $ (0.24 )   $ 0.05     $ (0.16 )   $ (0.40 )
    


 


 


 


Diluted earnings (loss) per share:                                 

Earnings (loss) per share before cumulative effect of accounting change

   $ (0.24 )   $ 0.05     $ (0.16 )   $ 0.11  

Cumulative effect of accounting change

     —         —         —         (0.51 )
    


 


 


 


Earnings (loss) per share

   $ (0.24 )   $ 0.05     $ (0.16 )   $ (0.40 )
    


 


 


 


Common and common equivalent shares outstanding:

                                

Basic

     28,888       29,020       28,676       28,953  

Diluted

     28,888       30,153       28,676       28,953  

 

 

-more-


MICROSEMI CORPORATION

Condensed Unaudited Consolidated Balance Sheets

(in thousands)

 

    

September 29,

2002


  

September 28,

2003


ASSETS              

Current Assets:

             

Cash and cash equivalents

   $ 23,060    $ 29,353

Accounts receivable, net

     32,435      28,866

Inventories

     52,040      53,679

Other Current assets

     6,434      6,473
    

  

Total current assets

     113,969      118,371

Property and equipment, net

     65,608      62,973

Other assets

     37,191      24,299
    

  

TOTAL ASSETS

   $ 216,768    $ 205,643
    

  

LIABILITIES AND SHAREHOLDERS’ EQUITY              

Current liabilities

   $ 29,922    $ 31,203

Long-term debt

     4,356      486

Other long-term liabilities

     4,044      4,094

Shareholders’ equity

     178,446      169,860
    

  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 216,768    $ 205,643